[
    "{\"step_by_step_thinking\": \"The increased standard error in the pulmharkimab 150 mg/day group suggests a smaller sample size or greater variability in the data compared to the other groups. This could be due to a smaller number of participants in the pulmharkimab 150 mg/day group or greater variability in their responses to the treatment. \", \"answer_choice\": \"C\"}"
]